구강암의 임상적 진단

Clinical Diagnosis of Oral Cancer

  • 최성원 (국립암센터 구강종양클리닉)
  • Choi, Sung Weon (Oral Oncology Clinic, Research Institute and Hospital, National Cancer Center)
  • 투고 : 2011.02.22
  • 심사 : 2011.03.22
  • 발행 : 2011.03.01

초록

Oral cavity cancer accounts for approximately 3-4% of all malignancies and is a significant worldwide health problem. The Korea Central Cancer Registry estimates that there will be approximately 1500 new cases of oral cancer in Korea. Oral cancer occurs most commonly in middle-aged and elderly individuals. The majority of oral malignancies occur as squamous cell carcinomas and despite remarkable advances in treatment modalities, the 5-year survival rate has not significantly improved over the past several decades, hovering at about 50% to 60%. The unfavorable 5-year survival rate may be attributable to several factors. First, oral cancer is often diagnosed at a late stage, with late stage 5-year survival rates as low as 22%. Additionally, the development of secondary primary tumors in patients with early stage disease has a major impact on survival. The early detection of oral cancer and premalignant lesions offers the promise to cure chance of oral cancer. The major diagnostics moddalities for oral cancer include oral cavity examination, supravital staining, oral cytology, and optical detection systems. But the clinical finding of oral mucosa is the most important key to confirm the oral cancer until now. The traditional clinical examination of oral cavity can be performed quickly, is without additional diagnostic expense to patients, and may be performed by health care professionals. Therefore, clinicians must be well-acquainted with clinical characteristics of oral cancer and practice routine screening for oral cancer in dental clinic to decrease the morbidity and mortality of disease.

키워드

참고문헌

  1. Kademani D. Oral cancer. Mayo Clin Proc 2007;82(7):878-87. https://doi.org/10.4065/82.7.878
  2. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcome, the trends, the challenge. J Am Dent Assoc 2001;132:7S-11S.
  3. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 2008;118:1350-6. https://doi.org/10.1097/MLG.0b013e318172ef9a
  4. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a followup study of 257 patients. Cancer 1984;53:563-8. https://doi.org/10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F
  5. Silverman S Jr. Observations on the clinical characteristics and natural history of leukoplakia. J Am Dent Assoc 1968;76:772-7. https://doi.org/10.14219/jada.archive.1968.0141
  6. Ellis GL, Jensen JL, Reingold IM. Malignant neoplasms metastatic to gingiva. J Oral Surg 1977:44;238-41. https://doi.org/10.1016/0030-4220(77)90274-2
  7. Friedrich RE. Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer : a report from a signvle institution in Han burg, Germany. Anticancer Res 2010:30:1833-6.
  8. Al-Dakkak I. Diagnostic delay broadly associated with ore advanced stage oral cancer.Evid Based Dent 2010:11:24. https://doi.org/10.1038/sj.ebd.6400708
  9. Gomez I, Warnakulasuriya S, Varela-Centelles PI, Lopez-Jornet P, Suarez-Cunqueiro M, Diz-Dios P, Seoane J. Is early diagnosis of oral cancer a feasible objective Who is to blame for diagnostic delay? Oral Dis 2010:16:333-42. https://doi.org/10.1111/j.1601-0825.2009.01642.x
  10. Baykul T, Yilmaz HH, Aydin U, Aydin MA, Aksoy M, Yildirim D. Eaely diagnosis of oral cancer. J Int Med Res 2010:38:737-49. https://doi.org/10.1177/147323001003800302